FORT LAUDERDALE, Fla., March 20, 2025 /PRNewswire/ — Discover the groundbreaking work of Starlight Cardiovascular, a company dedicated to creating life-saving technologies for children with congenital heart disease, a condition affecting countless families nationwide. Starlight…
Author: Ken Dropiewski
Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated impact on vital treatments Funding will also support clinical uptake of its breakthrough solution in lung fibrosis OXFORD, England and CHICAGO, March…
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment
More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking WEB™…
T45 LABS CLOSES OVERSUBSCRIBED $25M T45 FUND I TO ACCELERATE MILESTONE ACHIEVEMENTS FOR PORTFOLIO COMPANIES
Use of Funds to Advance Delivery of Breakthrough Cardiovascular Medical Devices To Large and Underserved Markets SANTA CLARA, Calif., March 19, 2025 /PRNewswire/ — T45 Labs, a specialized medical technology innovation company focused on accelerating the development of cardiovascular…
AngioInsight, Inc. Announces the SMARTFLOW Pivotal Clinical Study
AI-Powered AngioAI+™ Platform to Enhance Cardiovascular Disease Diagnosis, Including Coronary Microvascular Disease (CMD) MINNETONKA, Minn.–(BUSINESS WIRE)–AngioInsight, Inc., a leader in AI-driven cardiovascular solutions, today announced the upcoming launch of its pivotal clinical study, SMARTFLOW ™, to evaluate the diagnostic accuracy and effectiveness of its innovative AngioAI+ platform. Designed to revolutionize angiography imaging […]
Elixir Medical Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
Developer of disruptive technologies to treat cardiovascular and peripheral disease joins the ranks of Waymo, Nvidia, Duolingo, and more MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping […]
Subtle Medical Advances GenAI Innovation in Radiology with NVIDIA
Leveraging NVIDIA’s Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization MENLO PARK, Calif., March 18, 2025 /PRNewswire/ — Medical imaging today faces several critical challenges. Imaging modalities like MRI, PET, and CT are used…
Ansys and NVIDIA to Demonstrate New Era of In-Silico Cardiovascular Research at GTC
Ansys and NVIDIA unveil vision for the future of cardiovascular research by democratizing simulation / Key Highlights Ansys and NVIDIA’s open-source technology narrows the gap between simulation and reality by enabling customized workflows, fostering collaboration, and making simulation…
First-in-Human Clinical Results for SonoVascular’s SonoThrombectomy™ System Presented at the 2025 Annual Meeting of the American Venous Forum
CHAPEL HILL, N.C., March 18, 2025 /PRNewswire/ — SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System for venous thromboembolism (VTE), a novel treatment solution intended to provide better outcomes for millions of…
Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
NEW YORK, March 18, 2025 /PRNewswire/ — Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric infarction (LHI) drug, CIRARA (IV glyburide). The…